文献速递功能神经外科

深部脑刺激治疗运动障碍疾病中的差异

Disparities in the treatment of movement disorders using deep brain stimulation.
PubMed 文献 · J Neurosurg · 2024-02-02

该研究利用美国全国住院患者样本数据库2012年1月1日至2019年12月31日的数据,分析帕金森病和特发性震颤患者接受深部脑刺激(DBS)治疗的种族、民族和性别差异。结果显示黑人和西班牙裔患者及女性接受DBS的可能性低于白人患者和男性。

要点

  • 帕金森病出院患者中1.2%接受DBS,特发性震颤出院患者中1.8%接受DBS。
  • 帕金森病患者中,黑人(OR 0.16)和西班牙裔(OR 0.76)接受DBS可能性低于白人。
  • 特发性震颤患者中,黑人、西班牙裔和亚裔/太平洋岛民接受DBS可能性均低于白人。

核心结论

  • 作者描述了帕金森病和特发性震颤患者中DBS使用存在显著的种族和性别差异。
  • 需要进一步研究以确定这些差异的原因,以及专科神经外科治疗可及性和神经调控转诊方面的任何差异。

研究设计与样本

  • 全国住院患者样本数据库查询,纳入2012年1月1日至2019年12月31日所有出院记录中ICD-9或ICD-10诊断为帕金森病或特发性震颤的患者。
  • 按种族、民族和性别亚组报告DBS率,所有分析均加权以形成全国估计。

主要发现

  • 帕金森病出院共2,517,639例,其中29,820例(1.2%)接受DBS;特发性震颤出院共652,935例,其中11,885例(1.8%)接受DBS。
  • 帕金森病患者中,黑人(n=405 [0.2%],OR 0.16,95%CI 0.12-0.20)较白人(n=23,975 [1.2%])接受DBS的可能性更低;西班牙裔(n=1965 [1.1%],OR 0.76,95%CI 0.65-0.88)亦更低;亚裔/太平洋岛民(n=855 [1.5%])与白人无统计学差异。
  • 特发性震颤患者中,黑人(n=230 [0.8%],OR 0.39,95%CI 0.27-0.56)、西班牙裔(n=215 [1.0%],OR 0.39,95%CI 0.28-0.55)和亚裔/太平洋岛民(n=55 [1.0%],OR 0.51,95%CI 0.28-0.93)较白人(n=10,440 [1.9%])接受DBS的可能性更低。
  • 女性较男性接受DBS治疗帕金森病(OR 0.69,p<0.0001)或特发性震颤(OR 0.70,p<0.0001)的可能性更低。

临床怎么用

  • 作者认为需要进一步研究以确定这些差异的原因,以及专科神经外科治疗可及性和神经调控转诊方面的任何差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Deep brain stimulation (DBS) is a well-established treatment for Parkinson's disease (PD) and essential tremor (ET). Although the prevalence of PD and ET can vary by sex and race, little is known about the accessibility of neurosurgical treatments for these conditions. In this nationwide study, the authors aimed to characterize trends in the use of DBS for the treatment of PD and ET and to identify disparities in the neurosurgical treatment of these diseases based on ethnic, racial, sex, insurance, income, hospital, and geographic factors. METHODS: Using the dates January 1, 2012, to December 31, 2019, the authors queried the National Inpatient Sample database for all discharges with an ICD-9 or ICD-10 diagnosis of PD or ET. Among these discharges, the DBS rates were reported for each subgroup of race, ethnicity, and sex. To develop national estimates, all analyses were weighted. RESULTS: Among 2,517,639 discharges with PD, 29,820 (1.2%) received DBS, and among 652,935 discharges with ET, 11,885 (1.8%) received DBS. Amid the PD cases, Black patients (n = 405 [0.2%], OR 0.16, 95% CI 0.12-0.20) were less likely than White patients (n = 23,975 [1.2%]) to receive DBS treatment, as were Hispanic patients (n = 1965 [1.1%], OR 0.76, 95% CI 0.65-0.88), whereas Asian/Pacific Islander patients (n = 855 [1.5%]) did not statistically differ from White patients. Amid the ET cases, Black (n = 230 [0.8%], OR 0.39, 95% CI 0.27-0.56), Hispanic (n = 215 [1.0%], OR 0.39, 95% CI 0.28-0.55), and Asian/Pacific Islander (n = 55 [1.0%], OR 0.51, 95% CI 0.28-0.93) patients were less likely than White patients (n = 10,440 [1.9%]) to receive DBS. Females were less likely than males to receive DBS for PD (OR 0.69, p < 0.0001) or ET (OR 0.70, p < 0.0001). CONCLUSIONS: The authors describe significant racial and sex-based differences in the utilization of DBS for the treatment of PD and ET. Further research is required to ascertain the causes of these disparities, as well as any differences in access to specialty neurosurgical care and referral for neuromodulation approaches.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Venkatraman V, Futch BG, Bode Padron KJ, et al. Disparities in the treatment of movement disorders using deep brain stimulation. J Neurosurg. 2024. PMID: 38306639. doi:10.3171/2023.11.JNS23882

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。